Given that p53 is highly activated in response to DNA damage, due to genotoxic treatments (e.g., doxorubicin), it is probable that the p53-miR-199a-3p-mTOR pathway regulates cancer cell survival during chemotherapy or radiotherapy. This evidence concerns the gene TP53 and cancer.